Stoke Therapeutics, Inc. (STOK)

36.64 +2.35 (+6.85%) USD  |  NASDAQ  |  Feb 23, 10:53
More

Stoke Therapeutics Stock Based Compensation (Quarterly)

Stock Based Compensation (Quarterly) Chart

View Stock Based Compensation (Quarterly) for STOK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Quarterly) Range, Past 5 Years

View Stock Based Compensation (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Quarterly) Benchmarks

View Stock Based Compensation (Quarterly) Benchmarks
Start Trial
Biogen, Inc. Upgrade
Insmed, Inc. Upgrade
Pfizer Inc. --
Mirum Pharmaceuticals, Inc. Upgrade
Moderna, Inc. Upgrade